Antila Lifesciences is a finished-dose manufacturer based in India. It appears in 49 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), NAFDAC (NG) and DIGEMAPS (DO). Its GMP standing is certified by CDSCO (India). Customs aggregates show $9.4M of exports covering 426 molecules to 17 destinations in 2025.
| Site | FDA FEI |
|---|---|
| tal kalolsantejgandhin agar, India | Not on file |
| Sabarkantha, India | Not on file |
| jarodvadoda ra, India | Not on file |
| ahmedabad, India | Not on file |
| kerala bavla kerala bavla ahmedabad, India | Not on file |
| sanand 382 110 ahmedabad, India | Not on file |
6 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 32 | None |
| NAFDAC (NG) | 7 | None |
| DIGEMAPS (DO) | 4 | None |
| FDA (GH) | 3 | None |
| MINSA (CR) | 2 | None |
| BOMRA (BW) | 1 | None |
| CDSCO (India) | None | 15 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.9M | 9 |
| 2025 | Not reported | $9.4M | 17 |
| 2024 | Not reported | $7.3M | 20 |
| 2023 | Not reported | $5.9M | 14 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Antila Lifesciences comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.